Out-of-pocket costs for brand-name drugs increased by 15 percent

A recent JAMA study found the median out-of-pocket costs increased by 15 percent for brand-name medications. The JAMA Network Open study found nearly 53.7 percent of patients paid drug deductible or coinsurance increased when manufacturers increased list prices. The study consisted of 79 brand-name drugs with available pricing data obtained from the national commercial insurance claims database from January 2015 to December 2017. For more details on the study findings, click here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org